For: | Ni Q, Chen Z, Yao HP, Yang ZG, Liu KZ, Wu LL. Inhibition of human La protein by RNA interference downregulates hepatitis B virus mRNA in 2.2.15 cells. World J Gastroenterol 2004; 10(14): 2050-2054 [PMID: 15237432 DOI: 10.3748/wjg.v10.i14.2050] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i14/2050.htm |
Number | Citing Articles |
1 |
J. Tang, Z.‐H. Zhang, M. Huang, T. Heise, J. Zhang, G.‐L. Liu. Phosphorylation of human La protein at Ser366 by casein kinase II contributes to hepatitis B virus replication and expression in vitro. Journal of Viral Hepatitis 2013; 20(1): 24 doi: 10.1111/j.1365-2893.2012.01636.x
|
2 |
J. Tang, Z.‐H. Zhang, G.‐L. Liu. A systematic analysis of the predicted human La protein targets identified a hepatitis B virus infection signature. Journal of Viral Hepatitis 2013; 20(1): 12 doi: 10.1111/j.1365-2893.2012.01626.x
|
3 |
J. Pan, S. Tong, J. Tang. LncRNA expression profiles in HBV‐transformed human hepatocellular carcinoma cells treated with a novel inhibitor of human La protein. Journal of Viral Hepatitis 2018; 25(4): 391 doi: 10.1111/jvh.12821
|
4 |
D Grimm, M A Kay. Therapeutic short hairpin RNA expression in the liver: viral targets and vectors. Gene Therapy 2006; 13(6): 563 doi: 10.1038/sj.gt.3302727
|
5 |
Akasit Visootsat, Sunchai Payungporn, Nattanan P. T-Thienprasert. A conserved RNA structural element within the hepatitis B virus post-transcriptional regulatory element enhance nuclear export of intronless transcripts and repress the splicing mechanism. Molecular Biology Reports 2015; 42(12): 1603 doi: 10.1007/s11033-015-3928-0
|
6 |
Su Jung Park, Hwa Jung Lee, Kwanuk Lee, Hunseung Kang. A La-Related Protein LaRP6a Delays Flowering of Arabidopsis thaliana by Upregulating FLC Transcript Levels. Journal of Plant Biology 2020; 63(5): 369 doi: 10.1007/s12374-020-09261-7
|
7 |
Michael D. Moore, Michael J. McGarvey, Rebecca A. Russell, Bryan R. Cullen, Myra O. McClure. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. The Journal of Gene Medicine 2005; 7(7): 918 doi: 10.1002/jgm.739
|
8 |
Yong Chen, Guofeng Cheng, Ram I. Mahato. RNAi for Treating Hepatitis B Viral Infection. Pharmaceutical Research 2008; 25(1): 72 doi: 10.1007/s11095-007-9504-0
|
9 |
Martin James Ross, Seth S. Bradford, J. A. Cowan. Catalytic metallodrugs based on the LaR2C peptide target HCV SLIV IRES RNA. Dalton Transactions 2015; 44(48): 20972 doi: 10.1039/C5DT02837J
|
10 |
Jing Tang, Zhi-Min Huang, Ying-Yi Chen, Zhao-Hui Zhang, Gao-Lin Liu, Jian Zhang, Jason Blackard. A Novel Inhibitor of Human La Protein with Anti-HBV Activity Discovered by Structure-Based Virtual Screening and In Vitro Evaluation. PLoS ONE 2012; 7(4): e36363 doi: 10.1371/journal.pone.0036363
|
11 |
Jia Zhang, Y. O. Wu, Li Xiao, Kai Li, L. L. Chen, P. Sirois. Therapeutic Potential of RNA Interference Against Cellular Targets of HIV Infection. Molecular Biotechnology 2007; 37(3): 225 doi: 10.1007/s12033-007-9000-0
|
12 |
Jiaqian Pan, Shuangmei Tong, Jing Tang. Alteration of microRNA profiles by a novel inhibitor of human La protein in HBV‐transformed human hepatoma cells. Journal of Medical Virology 2018; 90(2): 255 doi: 10.1002/jmv.24941
|
13 |
J. Haasnoot, B. Berkhout. RNA Towards Medicine. Handbook of Experimental Pharmacology 2006; 173: 117 doi: 10.1007/3-540-27262-3_7
|
14 |
Mark A. Bayfield, Ruiqing Yang, Richard J. Maraia. Conserved and divergent features of the structure and function of La and La-related proteins (LARPs). Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2010; 1799(5-6): 365 doi: 10.1016/j.bbagrm.2010.01.011
|
15 |
Shuangmei Tong, Jiaqian Pan, Jing Tang. Study on the structure optimization and anti‐hepatitis B virus activity of novel human La protein inhibitor HBSC11. Journal of Medical Virology 2019; 91(10): 1818 doi: 10.1002/jmv.25528
|